Skip to main content
Livermore
Livermore
ZHEN

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

Holdings in Q3 2024

Holdings as of Sep 30, 2024, filed Nov 13, 2024. Long positions only; changes compare share counts with Q2 2024.

Institution overview
Positions
77
−9 vs. Q2 2024
Portfolio value
$644.5M
+$9.64M (+1.5%) vs. Q2 2024
Filed
Nov 13, 2024
SEC
Holdings of Affinity Asset Advisors, LLC in Q3 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
XENEXenon Pharmaceuticals Inc.COM1,144,021$45.0M7.0%+149,794+15.1%AddedHistory
APGEApogee Therapeutics, Inc.COM664,198$39.0M6.1%−172,085−20.6%ReducedHistory
NUVLNuvalent, Inc.COM337,500$34.5M5.4%+137,500+68.8%AddedHistory
ACLXArcellx, Inc.COMMON STOCK400,000$33.4M5.2%−60,000−13.0%ReducedHistory
ALKSAlkermes plc.SHS1,000,000$28.0M4.3%+350,000+53.8%AddedHistory
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS1,400,000$25.2M3.9%−50,000−3.4%ReducedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM100,000$21.2M3.3%−10,000−9.1%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM400,000$20.4M3.2%−115,000−22.3%ReducedHistory
NRIXNurix Therapeutics, Inc.COM860,399$19.3M3.0%−51,601−5.7%ReducedHistory
VERAVera Therapeutics, Inc.CL A435,000$19.2M3.0%+60,000+16.0%AddedHistory
VRNAVerona Pharma plcSPONSORED ADS650,000$18.7M2.9%−50,000−7.1%ReducedHistory
AUTLAutolus Therapeutics plcSPON ADS4,500,000$16.3M2.5%+200,000+4.7%AddedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS965,612$15.4M2.4%−170,090−15.0%ReducedHistory
INZYInozyme Pharma, Inc.COM2,822,318$14.8M2.3%−33,934−1.2%ReducedHistory
SYRESpyre Therapeutics, Inc.COM NEW498,420$14.7M2.3%−15,000−2.9%ReducedHistory
Omeros Corp682143AG7NOTE 5.250% 2/1–$14.6M2.3%–––
KURAKura Oncology, Inc.COM687,785$13.4M2.1%+37,785+5.8%AddedHistory
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$13.1M2.0%–––
ESTAEstablishment Labs Holdings Inc.COM290,447$12.6M1.9%+67,040+30.0%AddedHistory
VRDNViridian Therapeutics, Inc.COM525,000$11.9M1.9%+375,000+250.0%AddedHistory
WVEWave Life Sciences, Inc.SHS1,400,000$11.5M1.8%+1,025,000+273.3%AddedHistory
Karyopharm Therapeutics Inc.48576UAA4NOTE 3.000%10/1–$9.62M1.5%–––
ORKAOruka Therapeutics, Inc.COM349,836$8.57M1.3%+349,836NewHistory
RZLTRezolute, Inc.COM NEW1,700,000$8.24M1.3%−150,000−8.1%ReducedHistory
MRUSMerus N.V.COM161,741$8.08M1.3%+36,741+29.4%AddedHistory
ATXSAstria Therapeutics, Inc.COM725,106$7.98M1.2%−250,500−25.7%ReducedHistory
ONCBeOne Medicines Ltd.ADR35,000$7.86M1.2%−75,000−68.2%ReducedHistory
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES472,390$7.84M1.2%+49,235+11.6%AddedHistory
BBIOBridgeBio Pharma, Inc.COM300,000$7.64M1.2%+200,000+200.0%AddedHistory
CLYMClimb Bio, Inc.COM1,500,000$7.63M1.2%−170,661−10.2%ReducedHistory
AXSMAxsome Therapeutics, Inc.COM80,000$7.19M1.1%00.0%UnchangedHistory
ERASErasca, Inc.COM2,499,431$6.82M1.1%00.0%UnchangedHistory
GERNGeron CorpCOM1,500,000$6.81M1.1%00.0%UnchangedHistory
CATXPerspective Therapeutics, Inc.COM NEW500,000$6.67M1.0%−50,000−9.1%ReducedHistory
IMVTImmunovant, Inc.COM225,000$6.41M1.0%−121,088−35.0%ReducedHistory
ARWRArrowhead Pharmaceuticals, Inc.COM325,000$6.30M1.0%+275,000+550.0%AddedHistory
PCVXVaxcyte, Inc.COM50,000$5.71M0.9%−10,000−16.7%ReducedHistory
ARVNArvinas, Inc.COM225,000$5.54M0.9%+225,000NewHistory
TERNTerns Pharmaceuticals, Inc.COM600,000$5.00M0.8%+600,000NewHistory
SWTXSpringWorks Therapeutics, Inc.COM147,500$4.73M0.7%+77,501+110.7%AddedHistory
CGEMCullinan Therapeutics, Inc.COM263,817$4.42M0.7%00.0%UnchangedHistory
Travere Therapeutics, Inc.89422GAA5NOTE 2.250% 3/0–$4.32M0.7%–New–
CLDXCelldex Therapeutics, Inc.COM NEW125,000$4.25M0.7%−350,400−73.7%ReducedHistory
MLYSMineralys Therapeutics, Inc.COM350,000$4.24M0.7%+22,041+6.7%AddedHistory
INSMINSMED IncCOM PAR $.0150,000$3.65M0.6%−75,000−60.0%ReducedHistory
FRNMFreenome, Inc.CL A ORD SHS350,000$3.51M0.5%00.0%UnchangedHistory
NXTCNextCure, Inc.COM2,302,598$3.15M0.5%+614,643+36.4%AddedHistory
SVRASavara IncCOM700,000$2.97M0.5%−846,850−54.7%ReducedHistory
NKTXNkarta, Inc.COM650,000$2.94M0.5%+450,000+225.0%AddedHistory
MIRMMirum Pharmaceuticals, Inc.COM75,000$2.92M0.5%−80,000−51.6%ReducedHistory
IMTXImmatics N.V.SHS250,000$2.85M0.4%−50,000−16.7%ReducedHistory
BBOTBridgeBio Oncology Therapeutics, Inc.CL A ORD SHS250,000$2.61M0.4%00.0%UnchangedHistory
CNTXContext Therapeutics Inc.COM1,321,153$2.59M0.4%−297,987−18.4%ReducedHistory
NARIInari Medical, Inc.Stock60,000$2.47M0.4%−140,000−70.0%ReducedHistory
ROIVRoivant Sciences Ltd.SHS201,587$2.33M0.4%−150,000−42.7%ReducedHistory
KZRKezar Life Sciences, Inc.COM2,511,778$1.94M0.3%+750,000+42.6%AddedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS300,512$1.89M0.3%−200,000−40.0%ReducedHistory
TECXTectonic Therapeutic, Inc.COM58,331$1.77M0.3%00.0%UnchangedHistory
NAMSWNewAmsterdam Pharma Co N.V.*W EXP 11/22/202212,974$1.49M0.2%+10,375+5.1%AddedHistory
SLNOSoleno Therapeutics IncCOM25,000$1.26M0.2%+25,000NewHistory
JBIOJade Biosciences, Inc.COM600,000$1.25M0.2%+400,000+200.0%AddedHistory
QTTBQ32 Bio Inc.COM27,777$1.24M0.2%00.0%UnchangedHistory
VSTMVerastem, Inc.COM NEW400,000$1.20M0.2%+400,000NewHistory
BMRNBiomarin Pharmaceutical IncCOM15,000$1.05M0.2%+15,000NewHistory
ZURAZura Bio LtdCLASS A ORD SHS223,335$906.7K0.1%00.0%UnchangedHistory
PBYIPuma Biotechnology, Inc.COM250,000$637.5K0.1%00.0%UnchangedHistory
RPTXRepare Therapeutics Inc.COM173,351$596.3K0.1%+173,351NewHistory
KYTXKyverna Therapeutics, Inc.COM119,900$586.3K0.1%−80,100−40.1%ReducedHistory
ADGMAdagio Medical Holdings, Inc.COM213,235$550.1K0.1%+213,235NewHistory
Immatics N.V.N44445117*W EXP 07/01/202187,204$430.6K0.1%00.0%Unchanged–
AVTXAvalo Therapeutics, Inc.COM NEW45,000$425.7K0.1%00.0%UnchangedHistory
VYGRVoyager Therapeutics, Inc.COM51,727$302.6K<0.1%+51,727NewHistory
MTVAMetaVia Inc.COM89,222$282.8K<0.1%00.0%UnchangedHistory
GNLXGENELUX CorpCOM100,000$237.0K<0.1%00.0%UnchangedHistory
WHWKWhitehawk Therapeutics, Inc.COM47,019$96.9K<0.1%+47,019NewHistory
PMNProMIS Neurosciences Inc.COM30,643$38.3K<0.1%−235,315−88.5%ReducedHistory
Rocket Pharmaceuticals, Inc.77313F114*W EXP 09/02/20275,000$5.25K<0.1%00.0%Unchanged–

Options (9)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Affinity Asset Advisors, LLC in Q3 2024
SecurityClassPutsCalls
FLNAFilana Therapeutics, Inc.COM$42.7M–
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS–$18.0M
ANABAnaptysbio, IncCOM$6.70M–
SPRYARS Pharmaceuticals, Inc.COM–$5.80M
NVAXNovavax IncCOM NEW–$3.79M
GALTGalectin Therapeutics IncCOM NEW$3.33M–
SMMTSummit Therapeutics Inc.COM–$3.07M
SYRSSyros Pharmaceuticals, Inc.COM NEW$2.65M–
IMVTImmunovant, Inc.COM–$2.22M

Sold out since Q2 2024 (20)

Positions held at the end of Q2 2024 that are gone from this filing.

Positions of Affinity Asset Advisors, LLC sold out since Q2 2024
SecurityClassShares in Q2 2024Value in Q2 2024% of portfolio in Q2 2024History
CERECerevel Therapeutics Holdings, Inc.COM500,000$20.4M3.2%History
BridgeBio Pharma, Inc.10806XAB8NOTE 2.500% 3/1–$17.3M2.7%–
Alnylam Pharmaceuticals, Inc.02043QAB3NOTE 1.000% 9/1–$16.2M2.6%–
MORFMorphic Holding, Inc.COM250,573$8.54M1.3%History
ELEVElevation Acquisition Group Inc.COM1,468,825$3.97M0.6%History
HLVXHilleVax, Inc.COM265,859$3.84M0.6%History
DYNDyne Therapeutics, Inc.COM100,000$3.53M0.6%History
State Street SPDR S&P Biotech ETF78464A870ETF37,550$3.48M0.5%–
BDTXBlack Diamond Therapeutics, Inc.COM650,000$3.03M0.5%History
OLMAOlema Pharmaceuticals, Inc.COM275,000$2.98M0.5%History
VIRVir Biotechnology, Inc.COM200,000$1.78M0.3%History
ZYMEZymeworks Inc.COM191,127$1.63M0.3%History
MRSNMersana Therapeutics, Inc.COM767,000$1.54M0.2%History
ARYDARYA Sciences Acquisition Corp IVCL A133,500$1.53M0.2%History
ADCTADC Therapeutics SASHS474,744$1.50M0.2%History
TNGXTango Therapeutics, Inc.COM150,274$1.29M0.2%History
ORKAOruka Therapeutics, Inc.COM72,484$277.6K<0.1%History
RAPTRAPT Therapeutics, Inc.COM75,000$228.8K<0.1%History
PASGPassage BIO, Inc.COM264,266$209.9K<0.1%History
IOVAIovance Biotherapeutics, Inc.COM100$802<0.1%History